Background: Venous thromboembolism prophylaxis remains underutilized in hospi-
| INTRODUC TI ON
Historical studies employing phlebography surveillance suggest that as many as 15% of hospitalized medical patients will develop venous thromboembolism (VTE) during hospitalization. [1] [2] [3] Contemporary evidence suggests that clinically overt thrombosis rates approximate 0.3% to 9.7% in hospitalized medical patients. 4, 5 In spite of these data, only about 40% of hospitalized medical patients at high risk for VTE receive appropriate thromboprophylaxis defined as chemoprophylaxis with low-molecular-weight heparin, unfractionated heparin, or fondaparinux. [6] [7] [8] Guideline authors have recommended adoption of formalized VTE risk assessment models [8] [9] [10] [11] [12] [13] that have been variably validated and compared, 14, 15 however, they have not been uniformly adopted. 16, 17 Selective application of venous thrombosis chemoprophylaxis reduces the number of adverse events associated with thromboprophylaxis such as bleeding and heparin-induced thrombocytopenia (HIT) 18, 19 by limiting chemoprophylaxis to only those patients likely to benefit. 20, 21 We along with others have reported that interventions to inform physicians of thrombosis risk and to provide guidance regarding appropriate thromboprophylaxis improve outcomes. 5, 22, 23 Electronic alerts have been described as one mechanism to positively impact appropriate thromboprophylaxis rates among some 4, [24] [25] [26] but not all 27 patient populations. The importance of a reliable methodology to identify patients at high risk for hospital-associated VTE and reduce that risk is highlighted by a recent Centers for Disease Control Hospital-Associated Venous Thromboembolism (HA-VTE) Reduction Challenge. 28 We previously reported a multifaceted intervention that was associated with improved thromboprophylaxis, improved chemoprophylaxis, a reduction of VTE, and was well-received by hospitalists in tertiary care metropolitan teaching hospitals. 5 We wished to assess the performance of the intervention in community hospitals.
Our primary objective was to report the rate of appropriate thromboprophylaxis among hospitalized medical patients at high risk for symptomatic VTE defined as the prescription of chemoprophylaxis or documenting a contraindication thereof following implementation of a multifaceted intervention including (i) targeted electronic alerts for high-risk patients, (ii) provision of comparative prophylaxis metrics to practitioners, and (iii) practitioner-specific continuing medical education. Eligible patients included those adults (≥18 years of age) admitted to the hospitalist service at the participating community hospitals for greater than 24 hours. Appropriate thromboprophylaxis rates were compared over a 3-year period.
Secondarily we report 30-and 90-day rates of symptomatic VTE, in-hospital major bleeding, in-hospital HIT, in-hospital and 90-day all-cause mortality, practitioner response to electronic messaging, alert fatigue, and practitioner satisfaction with the intervention. The
Intermountain Healthcare Institutional Review Board approved this study (Institutional Review Board # 1019819).
| METHODS
The multifaceted healthcare quality improvement initiative entitled the Venous Thromboembolism Reduction Initiative II (VRI II), was presented to the hospitalists at each hospital's monthly meeting and each hospitalist provided voluntary signed informed consent to participate in this initiative that was recognized as a value-based incentive project for each hospitalist group. Three community hospitals participated in VRI II (Hospital 1, Hospital 2, and Hospital 3).
As we formerly reported 5 the VRI consisted of three interventions.
The first intervention was delivery of an electronic alert. To generate this, we developed an electronic VTE risk assessment model 26, 29 which interrogated the electronic medical record daily and generated a VTE risk score classifying each patient as being either high risk for VTE (a VTE risk score of ≥4 as defined by Kucher et al) 26 or not (a VTE risk score <4 
Essentials
• Multidisciplinary VTE Reduction initiative was conducted at three community hospitals over 3 years.
• All hospitalists at three Intermountain Healthcare community hospitals participated.
• Compared with the control year, appropriate thromboprophylaxis improved over the two subsequent years.
• Providing just-in-time alerts and education re: thrombosis risk may protect patients from VTE.
of recommended doses of the aggregate of unfractionated heparin, low-molecular-weight heparin, or fondaparinux, the specific details on the type of prophylaxis were not recorded. If a high-risk patient not receiving prophylaxis was detected, then an electronic alert was generated reminding the responsible hospitalist to consider prophylaxis. Second, an audit-and-feedback assessment of each hospitalist's VTE prophylaxis rates generated a monthly report of each hospitalist's performance in comparison with their de-identified peers. Third, a proprietary targeted online continuing medical education activity was completed by each hospitalist. We assessed the effect of all three of these during the "intervention" phase of the trial. During the "maintenance" phase, only the alert intervention was continued. The primary outcome was prescription of appropriate VTE thromboprophylaxis defined as the prescription of guideline recommended chemoprophylaxis, or notation of a chemoprophylaxis contraindication during the intervention and maintenance periods among medical patients identified as being at high risk for venous thrombosis. We also report chemoprophylaxis. This was measured for each patient each day.
Venous thrombosis was identified using natural language processing interrogation of the electronic medical record, using methods we have previously described. 30 For a patient to be considered at high risk for VTE, they must have spent greater than 50% of the hospitalization classified as high risk.
Hospital-associated major bleeding was identified by electronic medical record interrogation as we have previously performed. 25, 31 We defined major bleeding by International Classification of Alert fatigue is described as the observation that interruptive alerts, if they occur too frequently or are felt to be clinically irrelevant in some instances, are associated with physicians ignoring the alert. 32, 33 In an attempt to measure if the hospitalists' experienced alert fatigue over the course of the study, the hospitalist response to the alert was captured. To report hospitalists' response to alerts we calculated the percent of patients for whom an alert was generated that subsequently had prophylaxis ordered, or contraindication for prophylaxis entered, within 24 hours.
| Statistical analysis
Demographic information was summarized overall as well as for the high-and non-high-risk groups (Table 1) . Demographic information was also summarized by period and found to be substantively stable across all 3 years of the study. The rates for all primary and secondary outcomes from the control period, intervention period, and maintenance period were formally compared using Chi-squared tests for proportions, or Fisher's exact test when appropriate. A significance level of 0.05 was used for all comparisons and multiple comparisons were controlled for using a false discovery rate of 5%.
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95% exact confidence intervals were also calculated for all primary and secondary outcomes. All analyses were conducted using the R Statistical Package. with the intervention period (85%; 95% CI 84%-86%) and the maintenance period (77%; 95% CI 76%-78%); P < .001 for all comparisons. The decrease in appropriate thromboprophylaxis comparing the intervention period (85%) to the maintenance period (77%) was significant; P < .001 (Figure 1 ). Hospitalists indicated a contraindication to thromboprophylaxis for 637 of 3267 (19%) of high-risk patient encounters in the intervention period and 341 of 3037 (11%) high-risk patient encounters during the maintenance period. The rate of chemoprophylaxis ordered comparing the control (67%) intervention (69%) and maintenance (67%) periods was unchanged. Figure 2 presents the rate of prescription of appropriate thromboprophylaxis by each individual hospitalist. All secondary outcomes are reported in Table 2 .
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| RESULTS
| Appropriate thromboprophylaxis
| Symptomatic VTE
The 90-day rate of symptomatic VTE among high-risk patients during the control period, the intervention period, and the maintenance period was 4.5%, 3.4%, and 3.0% respectively, and decreased significantly (P = .039; Figure 3 ). The 30-day rate of symptomatic VTE among high-risk patients during the control period, the intervention period, and the maintenance period was 3.5%, 2.5%, and 2.3%
respectively, and decreased significantly (P = .046).
| Major bleeding
Major bleeding among patients at high risk for venous thrombosis that received ≥1 dose of chemoprophylaxis compared with those 
| HIT
Among high-risk patients that received ≥1 dose of chemoprophylaxis, in-hospital heparin-induced thrombocytopenia was rare and occurred at a rate of 0.38% in the control, 0.21% in the intervention, and 0.09% in the maintenance period. The rate of in-hospital heparin-induced thrombocytopenia was not significantly different from year to year (P = .15).
| Mortality
Among high-risk patients neither the rate of in-hospital mortality (control: 4.6%; intervention: 3.6%; maintenance period: 4.4%; P = .15) nor the 90-day mortality rate (control: 16.3%; intervention:
14.5%; maintenance period: 16.0%; P = .15) differed significantly.
| Alert fatigue
During the intervention period, 1993 alerts were sent, while 2446
were sent during the maintenance period. We observed differences between the community hospitals and our prior intervention in teaching hospitals. These differences included that in community hospitals there was no change in the rate of chemoprophylaxis comparing the control period with the intervention period and the maintenance period, and the documentation of a chemoprophylaxis contraindication decreased from the intervention period to the maintenance period; while both rates increased over the analogous time interval at teaching hospitals. Our observations are important because the comparative effectiveness of interventions such as ours in community hospitals vs academic centers is limited. Others have reported lower rates of appropriate chemoprophylaxis among community hospitals when compared with academic institutions. 36 We conclude that the reduction in appropriate thromboprophylaxis rates comparing the intervention to maintenance periods reflected the community hospitalists no longer taking the time to document contraindications during the maintenance period. These observations suggest that the community hospitalists may have become less engaged with the electronic tool when moving from the intervention period to the maintenance period. We hypothesize that the audit-and-feedback and/or continuing medical education (CME) components provided to the hospitalists during the TA B L E 2 Rate of VTE, mortality, major bleeding, and heparin induced thrombocytopenia for high-risk patients CI, confidence interval; HIT, heparin-induced thrombocytopenia; VTE, venous thromboembolism. a Controlled for multiple comparisons using a false discovery rate of 5%. b Pairwise tests: Control period is significantly different from the intervention period (P = .03), but the intervention period is not significantly different than the follow up period (P = .47). c Pairwise tests: Control period is significantly different from the intervention period (P = .03), but the intervention period is not significantly different than the follow up period (P = .69). d In the control period no alert was sent, however it would have been given the criteria applied during the intervention period and follow-up year. e In the control period no alert was sent, however it would have been given the criteria applied during the intervention period and follow up year. f Thromboprophylaxis is defined as ever receiving a dose of chemoprophylaxis.
Bold values represents the statistically significant value (P ≤ .05). A reduced rate of symptomatic VTE among high-risk medical inpatients was observed and sustained. We hypothesize that the VRI II engaged hospitalists and broadened their awareness of the importance of general thromboprophylaxis strategies among hospitalized patients (perhaps including unmeasured factors, such as emphasizing early and frequent ambulation and the use of sequential pneumatic compression devices). Likewise, we observed that the best chemoprophylaxis rates occurred during the intervention year, when the full package of interventions (alerting, audit-andfeedback and tailored CME) were active. This suggests that a multicomponent intervention may be more effective than a simple alert system. Finally, secular pressures to reduce HA-VTE rates in an era of VTE reduction performance metrics may have also influenced our observed results.
The rate of major bleeding did not differ during the initiative;
an observation that is consistent with reports of prior randomized controlled trials of VTE prophylaxis, 1-3 our previous study, 5 and previous studies assessing utility of electronic alerts to improve chemoprophylaxis. 5, 11, 16, 26 We attribute the higher rate of major bleeding among those patients for whom chemoprophylaxis was withheld to the hospitalists (appropriately) refraining from prescribing chemoprophylaxis to patients that were at an increased risk for bleeding. The overall rate of HIT we observed was low and analogous to previously reported rates by others 20,37-39 and ourselves. 5 While a nonsignificant decrease in HIT was observed, no organized program to mitigate HIT risk occurred during the study.
In-hospital and 90-day all-cause mortality did not differ between years.
More alerts (n = 2446) were sent during the maintenance period compared with the intervention period (n = 1993). We observed a significant 22.4% (95% CI: 19.6%-25.3%, P < .001) reduction in the response to alerts sent during the maintenance period compared with the intervention period, and the rate of appropriate thromboprophylaxis did not increase. We cannot exclude the possibility that the hospitalists found the alerts of limited/no utility and therefore responded to fewer alerts over time, which could be indicative of alert fatigue. No change in chemoprophylaxis ordered comparing the control, intervention, and maintenance periods supports this hypothesis. Our ongoing research is assessing the variables that effect hospitalists' prescriptive behavior and response to alerts in the hopes of improving the efficiency and utility of future alerting.
Strengths of our study included that we performed this intervention at three community hospitals with multiple hospitalist groups and with 100% of hospitalists participating. We reported 3 years of data captured and follow-up and described in detail our initiative.
Our initiative was accompanied by reduced rates of symptomatic VTE over time. We achieved 100% electronic follow-up for the secondary outcomes reported.
Limitations of our study include those attributable to performing this prospective interventional study in the setting of routine clinical practice. These include the secular influences surrounding VTE prophylaxis and those attributable to clinical care. Because all hospitalists provided signed informed consent, we cannot refute the possibility that a Hawthorne effect led to a higher rate of chemoprophylaxis during the control period than would otherwise have existed. Because we reported chemoprophylaxis as the aggregate of guideline-recommended dosing for unfractionated heparin, low-molecular-weight heparin, and fondaparinux, we cannot quantitatively explore whether there was a change in the type of prophylaxis being used. However, the practice of our hospitalists is to primarily (~80% of the time) prescribe lowmolecular-weight heparin, prescribe unfractionated heparin ~20% of the time, and rarely prescribe fondaparinux. We were not able to report the prescription or utilization of mechanical prophylactic devices (not captured electronically at our hospitals) or institution-specific initiatives to reduce the burden of thromboembolic disease. Additionally, our study was limited by the constraints of defining thrombosis outcomes using natural language processing and an inability to capture patient events that occurred outside our hospital system. However we have reported a high degree of accuracy in the utility of this approach to identify patients with thrombosis.
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In conclusion, the VRI II was associated with a significant increase in appropriate thromboprophylaxis of medical inpatients driven by hospitalists engaging with VRI II to identify contraindications to chemoprophylaxis; although no increase in chemoprophylaxis prescription occurred. We cannot exclude the possibility of alert fatigue as evidenced by a reduction in hospitalist response to alerts generated over time. Optimal thromboprophylaxis was coincident with a targeted CME initiative. We report an overall reduction and sustained 
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